Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Acquisitions & Divestments: 2020-2025

  • Roivant Sciences' Change in Acquisitions & Divestments was N/A to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year change of. This contributed to the annual value of $2.0 billion for FY2025, which is N/A change from last year.
  • Latest data reveals that Roivant Sciences reported Change in Acquisitions & Divestments of $1.1 billion as of Q3 2025, which was up 53.47% from $720.0 million recorded in Q2 2025.
  • Over the past 5 years, Roivant Sciences' Change in Acquisitions & Divestments peaked at $1.1 billion during Q3 2025, and registered a low of $320.2 million during Q4 2021.
  • For the 2-year period, Roivant Sciences' Change in Acquisitions & Divestments averaged around $928.3 million, with its median value being $960.0 million (2024).
  • Data for Roivant Sciences' Change in Acquisitions & Divestments shows a peak YoY surged of 200.00% (in 2021) over the last 5 years.
  • Over the past 3 years, Roivant Sciences' Change in Acquisitions & Divestments (Quarterly) stood at $320.2 million in 2021, then followed by $960.0 million in 2024, then followed by $1.1 billion in 2025.
  • Its Change in Acquisitions & Divestments was $1.1 billion in Q3 2025, compared to $720.0 million in Q2 2025 and $960.0 million in Q4 2024.